Learning Objectives

After completion of this module, you should be able to:

  • Recognize the different causes of eczema including the differential diagnosis of AD
  • Describe the different forms of treatment for AD
  • Identify the side effects of topical corticosteroids
  • Discuss the adverse effects of oral immunosuppressive agent including oral corticosteroids,  used in atopic dermatitis 

 

Faculty & Disclosures

Luz  Fonacier, MD, FACAAI: Genentech- Research Grant; Merck- Research Grant; Baxter- Research Grant, Speaker; Church and Dwight, Co., Inc- Consultant

Mark Boguniewicz, MD, FACAAI: Anacor – Research Grant, Celgene, Regeneron – Advisory Board 

Peter Lio: Anacor- Advisory Board; DermTap, Inc.-Advisory Board, Stock Options; Exeltis- Consultant; Ferndale Laboratories-  Speaker; Galderma Laboratories, L.P.- Speaker, Consultant; IntraDerm Pharmaceuticals- Advisory Board;Johnson & Johnson- consultant, speaker, Advisory Board, Research Grant

Peck Ong, MD, FACAAI: Atopic dermatitis Research Network- Research Grant; Tioga – Research Grant; Regeneron – Advisory Board.

Gerald B. Lee, MD: Nothing to Disclose

CME Statement

Accreditation

The American College of Allergy, Asthma & Immunology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology designates this PI CME activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.